Population pharmacokinetic and exposure-response analysis of nilotinib in patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase
Richard A. Larson, Ophelia Q. P. Yin, Andreas Hochhaus, Giuseppe Saglio, Richard E. Clark, Hirohisa Nakamae, Neil J. Gallagher, Eren Demirhan, Timothy P. Hughes, Hagop M. Kantarjian, Philipp D. le CouVolume:
68
Language:
english
Pages:
11
DOI:
10.1007/s00228-011-1200-7
Date:
May, 2012
File:
PDF, 1.41 MB
english, 2012